Rezolute announces FDA meeting results via press release

Filed March 24, 2026 · Period ending March 24, 2026 · ~1 min read

Key Changes

• medium

  Rezolute held a meeting with the FDA and issued a press release on March 24, 2026 announcing the results. The 8-K does not disclose specific outcomes or content from the FDA discussion.

  Item 7.01 verify on EDGAR →
• medium

  Filing made under Regulation FD Disclosure, indicating the company is publicly releasing information to comply with fair disclosure rules. The actual press release is attached as Exhibit 99.1.

  Item 7.01, Exhibit 99.1 view on EDGAR →